Pilot study demonstrates over 50% reduction in menstrual blood loss and improved symptoms using non-invasive, drug-free therapy
Selected amongst global academic institutions to conduct a pivotal trial for heavy menstrual bleeding
OhmBody, a new "science-forward" division of Spark Biomedical, targets women's monthly period symptoms with $719 earpiece that uses nerve stimulation following Spark's $15M Series A funding round in April.
